NCI “Month” Appropriate For May, With Several Major Decisions Pending got Start Next 50 Years
In Brief: Donald Metcalf Wins Bristol-Myers Award; NCI Starts Search for Biological Carcinogenesis AD
FDA Committee IK IL-2/LAK For Modified Group C
Women PIs Score Highest In RFA To Encourage Early Breast Cancer Detection
ASCO To Include Chernobyl Talk, Educational sessions
ACS To Continue Supporting Both Treatment, Prevention Research, Leaders Say
St. Vincent Of NYC Joins Funded CCOPS Spurr To Be Professor Emeritus; UCOG, Still Unfunded, Still Active
FDA Offers Grants For Conferences
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ - NCI’s Philip Castle on NHS-Galleri results: “I’m sorry that it didn’t work, but it keeps the national conversation going.”
Castle is “disappointed” by Galleri results but not discouraged by implications for MCDs
